An interventional study of Krill Oil and Vegetable Oil in Diabetes Mellitus, Type 2, sponsored by Dasman Diabetes Institute. Recruiting at 1 site in Kuwait. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2023-09-13.
Sponsored by Dasman Diabetes Institute · Not applicable, Interventional, and Treatment
The age-related loss of muscle mass and function, sarcopenia, has several deleterious effects, such as a reduction in the quality of life and an increase in the incidence of falls, often leading to hospitalisation. The prevalence of sarcopenia is unclear but is estimated to be between 4.6 and 7.9% and the loss of skeletal muscle mass and function is accelerated in people with type 2 diabetes. With the percentage of older people and the percentage of people with type 2 diabetes predicted to rise in coming years it is crucial to develop therapies to increase muscle mass and function. Alterations in nutrition have also been suggested to be of therapeutic use in sarcopenia. Epidemiological data showed that the consumption of fatty fish is positively associated with muscle function in older population, indicating a potential role for long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFA) in increasing muscle mass and function in older people. The aim of the current study, therefore, is to determine the effects of krill oil supplementation on muscle size and function in adults with muscle weakness and type 2 diabetes.
10,371 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,406 are open to participants now.
This study's planned enrollment of 150 is above the median of 80 across 8,350 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Dasman Diabetes Institute is the lead sponsor of 31 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
vegetable oil 4g/day
Dietary Supplement: Vegetable Oil
Krill Oil 4g/day
Dietary Supplement: Krill Oil
Krill oil supplements 4g/day
vegetable oil supplements 4g/day
Grip strength
Change in Grip strength
Time frame: Change from baseline to one year
SPPB
Change in Short performance physical battery test
Time frame: Change from baseline to one year
HbA1c
Change in glycated haemoglobin
Time frame: Change from baseline to one year
Blood pressure
Change in blood pressure
Time frame: Change from baseline to one year
body mass
Change in body mass
Time frame: Change from baseline to one year
Lean mass
Change in lean mass
Time frame: Change from baseline to one year
Body fat
Change in body fat
Time frame: Change from baseline to one year
BMC
Change in bone mineral content
Time frame: Change from baseline to one year
BMD
Change in bone mineral density
Time frame: Change from baseline to one year
Erythrocyte fatty acid profile
Change in Erythrocyte fatty acid profile
Time frame: Change from baseline to one year
Started May 2022 (actual). Primary completion is estimated for Aug 2024, 27 months after the start.
Of 2,066 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 27 months is above that.
Counting every sponsor, half of 2,243 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Krill oil
Dasman Diabetes Institute